Skip to content
Screener

Pfizer PFE Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$14.7BBeat by $1.1B
EPS$0.78Beat by $0.20
Revenue estimate$13.6B
EPS estimate$0.58

Next report

Nov 3, 2026 (in a month)
Revenue estimate$15.9B
EPS estimate$0.77

Financials

Q2 2025

Income statement

See full
Revenue$14.7B+10.3%
Gross profit$10.9B+8.9%
Net income$2.9B+6,998%
EPS (diluted)$0.51+5,000%

Balance sheet

See full
Cash & equivalents$1.7B+50.8%
Total debt$61.7B+0.8%
Total equity$88.7B+1.1%
Total assets$206.10B-4.7%

Cash flow

See full
Operating cash flow-+100%
CapEx$618.0M-3.0%

Valuation & ratios

Valuation

as of 06/29/25
See full
Market cap$138.21B-12.7%
Enterprise value$198.27B-9.2%
P/E12.9×—
P/S2.2×-0.7×

Profitability

See full
Gross margin72.1%+13.9pp
Net margin16.8%—

Returns & leverage

See full
Return on equity12.2%—
Debt / equity0.7×0.0×
Current ratio1.2×+0.3×

Segments

By product

See full
Eliquis$2.0B+6.7%
Vyndaqel family$1.6B+22.1%
Prevnar Family$1.4B+1.8%
Ibrance$1.0B-7.2%
All other Primary Care$736.0M-3.0%

By geography

See full
International Developed Markets$3.4B+7.2%
International Emerging Markets$2.4B+6.2%

By segment

See full
Biopharma$14.3B+10.1%

FAQ

When did Pfizer report Q2 2025 earnings?
Pfizer (PFE) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Pfizer's Q2 2025 revenue and EPS?
Pfizer reported revenue of $14.7B and eps of $0.78 for Q2 2025.
Did Pfizer beat estimates in Q2 2025?
Revenue beat the consensus estimate of $13.6B by $1.1B. EPS beat the consensus estimate of $0.58 by $0.20.
How did Pfizer's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.3% from $13.3B a year earlier and eps grew 30.0% from $0.60.
Where can I find Pfizer's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000078003-25-000136) and the 10-Q periodic report (0000078003-25-000138) directly on SEC EDGAR. The filing index links above go to sec.gov.